Information Provided By:
Fly News Breaks for September 11, 2019
ENDP
Sep 11, 2019 | 16:41 EDT
Guggenheim analyst Dana Flanders assumed coverage of Endo International with a Neutral rating and a $2-$4 fair value range. The analyst noted that the upcoming opioid litigation, which Endo has significant exposure to, will be hard to call, but he estimates $3B-$4B in opioid liability paid out over ten years, and believes the risks are already reflected in the stock.
News For ENDP From the Last 2 Days
There are no results for your query ENDP